Director

Merilee Raines

Director; Chairperson of the Audit Committee·TransMedics Group, Inc.

About

Merilee Raines has served on the TransMedics Board since January 2021 and chairs the Audit Committee.

She served as Chief Financial Officer of IDEXX Laboratories, Inc. from October 2003 until her retirement in May 2013, after holding several management positions there including Corporate Vice President of Finance, Vice President and Treasurer of Finance, Director of Finance, and Controller.

She holds a mathematics degree from Bowdoin College and an MBA from the University of Chicago.

Since January 2021
Age 70
Tenure 5 yrs

Also at TransMedics Group, Inc.

WM Waleed H. Hassanein, M.D. Founder, President and Chief Executive Officer; Director JT James R. Tobin Director; Chairperson of the Board EB Edward M. Basile Director; Chairperson of the Nominating and Corporate Governance Committee TG Thomas J. Gunderson Director; Chairperson of the Compensation Committee EJ Edwin M. Kania, Jr. Director SL Stephanie Lovell Director

Roles

Organization Role Dates Details
TransMedics Group, Inc. Director; Chairperson of the Audit Committee January 2021–present Current role
IDEXX Laboratories, Inc. Chief Financial Officer October 2003-May 2013 Retired in May 2013.
IDEXX Laboratories, Inc. Corporate Vice President of Finance; Vice President and Treasurer of Finance; Director of Finance; Controller Several management positions held prior to becoming CFO.

External roles

Organization Role Dates
Watts Water Technologies, Inc. Director (audit and nominating and corporate governance committees) 2011-present
Ocular Therapeutics, Inc. Director (audit committee) September 2021-present
Benchmark Electronics, Inc. Director 2018-2021
Excelitas Technologies Corporation Director (private company) 2018-present
Dead River Company Director (private company) 2018-2021

Related

Source: TransMedics Group, Inc. proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo